Skip to main content

Science program for blind/low vision kids

Gear Up for Greatness! National Federation of the Blind

2010 Junior Science Academy

A STEM Program for Blind Children

Ages 8-12

Baltimore, Maryland, at the NFB Jernigan Institute

In 2008, the National Center for Blind Youth in Science (NCBYS), a program of the National Federation of the Blind Jernigan Institute, offered its first Science Academy program for elementary students. Once again, we are making this program possible for children in grades three through six. The NCBYS developed its Junior Science Academy (JSA) in 2004 in order to spark and enhance blind students’ interest in scientific study, an academic area that many falsely believe is too difficult for the blind. This year, with hands-on experiences, tactile materials, and innovative nonvisual teaching methods, the JSA will open its doors again to young explorers with two sessions of the program. Applicants can apply for one of the following dates:


Session 1: July 28-August 1, 2010

Session 2: August 4-August 8, 2010


The Junior Science Academy is a four-day session that will expose blind children to the excitement of science in real-life applications. The students will learn about how much fun science can be through hands-on instruction, field trips, and interactive activities. Attending parents will participate in a corresponding seminar with workshops designed to focus on meeting the needs of their blind children.


A registration fee of $150.00 will be charged for each accepted student and parent/chaperone pair. The cost of travel, room, board, and program materials will be covered by the NFB Jernigan Institute for all student and parent/chaperone pairs.

Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for
1 comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria
Post a Comment
Read more